Cardiac Surgery in Jehovah’s Witnesses

  • Todd K. Rosengart
Chapter

Abstract

The Jehovah’s Witnesses are members of a religious organization that was founded in the 1870s as a nondenominational Christian study group by a Pennsylvanian named Charles Taze Russell.1 The Watch Tower Bible and Tract Society was formed in 1881. The Watch Tower Society was headquartered in Brooklyn, New York in 1909, and has subsequently grown into an international organization with more than 5 million followers worldwide. The name “Jehovah’s Witnesses,” adopted by the Society in 1931, was derived from the Biblical passage, “You are my witnesses, saith Jehovah” (Isaiah 43:10).

Keywords

Placebo Albumin Income Aspirin Heparin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Vercillo AP, Duprey SV. Jehovah’s Witnesses and the transfusion of blood products.NY State J Med 1988;88(9):493–494.Google Scholar
  2. Questions from Readers.The WatchTower June 1, 1990;30–31.Google Scholar
  3. Questions from Readers.The WatchTowerMarch 1, 1989;30–31. Jehovah’s Witnesses—the surgical ethical challenge.JAMA1981; 246: 2471.Google Scholar
  4. Jehovah’s Witnesses—The surgical ethical challenge.Awake 1986;5.Google Scholar
  5. 5.
    Byrn RW. Compulsory lifesaving treatment for the competent adult.Fordham L Ren 1975;44:23–24.Google Scholar
  6. 6.
    Findley LJ, Fletcher JC. Jehovah’s Witnesses and the right to refuse blood.NY State J Med 1988;88(9):464–465.Google Scholar
  7. 7.
    Rosengart TK, Helm RE, Klemperer J, Krieger K, Isom OW. Combined aprotinin and eyrthropoietin use: results with Jehovah’s Witnesses.Ann Thorac Surg 1994;58:1397–1403.PubMedCrossRefGoogle Scholar
  8. 8.
    Rosengart TK, Helm B, Velasco F, et al. Open heart surgery without transfusion: a multimodality strategy in over forty consecutive Jehovah’s Witness patients.J Am Coll Cardiol 1996;27(2)(suppl A):231A.CrossRefGoogle Scholar
  9. 9.
    Rosengart TK. Risk analysis of primary versus reoperative coronary bypass surgery.Ann Thorac Surg 1993;56:S74–77.PubMedCrossRefGoogle Scholar
  10. 10.
    Helm RE, Klemperer JD, Rosengart TK, et al. Intraoperative autologous donation: volume-dependent red cell preservation.Am Coll Surg Surg Forum 1994;45:249–252.Google Scholar
  11. 11.
    Helm RE, Gold JP, Isom OW, Rosengart TK, Zelano JA, Krieger KH. Erythropoietin in cardiac surgery.J Cardiovasc Surg1993; 8: 579 – 606.Google Scholar
  12. 12.
    Rosengart TK, DeBois B, Helm R, et al. Retrograde autologous priming (RAP) for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements.Circulation 1995;92(8 Suppl):I763.Google Scholar
  13. 13.
    Levy JH, Pifarre R, Schaff H, et al. A multicenter, double-blind, placebo- controlled trial of aprotinin for reducing blood loss and the requirement for donor blood transfusion in patients undergoing repeat coronary artery bypass grafting.Circulation 1995;92:2236–2244.PubMedGoogle Scholar
  14. 14.
    Fremes SE, Wong BI, Lee E, et al. Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding.Ann Thorac Surg 1994;58:1580–1588.PubMedCrossRefGoogle Scholar
  15. 15.
    Blahut B, Harringer W, Bettelheim P, Doran JE, Spath P, Lundsgaard-Hansen P. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass.J Thorac Cardiovasc Surg 1994;108(6):1083–1091.Google Scholar
  16. Rosengart TK, Helm B, Velasco F, et al. Open heart surgery without transfusion: a multimodality strategy in fifty consecutive Jehovah’s Witness patients. J Am Coll Surg(in press).Google Scholar
  17. 17.
    Ott DA, Cooley DA. Cardiovascular surgery in Jehovah’s Witnesses: report of 542 operations without blood transfusion.JAMA 1977;238:1256–1258.PubMedCrossRefGoogle Scholar
  18. 18.
    Gaudiani VA, Mason HDW. Preoperative erythropoietin in Jehovah’s Witnesses who require cardiac procedures.Ann Thorac Surg 1991;51:823–824.PubMedCrossRefGoogle Scholar
  19. 19.
    Mann MC, Votto J, Kambo J, McNamee M. Management of the severely anemic patient who refuses transfusion: lessons learned during the case of a Jehovah’s Witness.Ann Intern Med 1992;117:1042–1048.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1998

Authors and Affiliations

  • Todd K. Rosengart

There are no affiliations available

Personalised recommendations